Wordt geladen...
The rise and fall of Dimebon
Dimebon (Latrepirdine) was initially developed in Russia as an over-the-counter antihistamine for allergy treatment. In early 1990s Dimebon was identified as a low affinity NMDA receptor antagonist, patented for treatment of neurodegenerative disorders and licensed by Medivation Inc. Extremely promi...
Bewaard in:
| Hoofdauteur: | |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2010
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3922928/ https://ncbi.nlm.nih.gov/pubmed/21031168 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1358/dnp.2010.23.8.1500435 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|